Monsanto led the plant genetics technology developer's series A round through its corporate venturing unit, and was joined by biotechnology company Novozymes.
Spain-based agricultural genetics technology developer PlantResponse Biotech has raised €5.7m ($6m) in a round led by Monsanto Growth Ventures, which invests on behalf of agribusiness Monsanto, Cinco Dias reported on Wednesday.
Monsanto was joined in the series A round by biotechnology producer Novozymes, Caixa Capital Risc, which acts as financial services firm La Caixa’s venture capital arm, and investment firm Middleland Capital.
Spun out of Universidad Politécnica de Madrid in 2008, PlantResponse is developing genetics technology intended to either improve…
